VAERS reports by lot

GSK Varicella/Shingles lot B327C: VAERS reports

63 VAERS reports list lot B327C as a GSK Varicella/Shingles vaccine, received between 2018-04-05 and 2020-03-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
11%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7529%
General / Systemic (non-local)6424%
Musculoskeletal3112%
Dermatological (non-injection-site)3011%
Neurological2510%
Allergic / Anaphylactic135%
Cardiac / Cardiovascular125%
Gastrointestinal104%
Respiratory21%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina7
Indiana6
Virginia5
California4
Massachusetts3
Tennessee3
Ohio3
New Mexico3
Maine3
Illinois3
Georgia2
Maryland2

Reports by month received

2018-0420
2018-0522
2018-069
2018-077
2018-091
2018-111
2019-041
2019-071
2020-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.